Stage IV Distant Mets or Stage III Unresectable
-
Melanoma
Stage IV Distant Mets or Stage III Unresectable
-
1st Line
-
2nd line or Above - BRAF Fusion
-
2nd Line and above
-
2nd Line BRAF V600 mutated
-
VICCMELP2274
Ph I Study of Nilotinib + Dabrafenib & Trametinib in BRAF V600 Melanoma After Prog on BRAF/MEK Inh
-
- Metastatic or unresectable melanoma.
- BRAF V600 mutation.
- Stable disease on dabrafenib and trametinib for a duration of greater than or equal to 6 months OR have failed any BRAFi/MEKi regimen to qualify for the trial, including the dabrafenib/trametinib combination.
-
-
-
Uveal
-